Chapter 51
Uveal Melanoma
Arun D Singh,
Paul A Rundle,
Ian G Rennie,
Arun D Singh
Search for more papers by this authorPaul A Rundle
Search for more papers by this authorIan G Rennie
Search for more papers by this authorArun D Singh,
Paul A Rundle,
Ian G Rennie,
Arun D Singh
Search for more papers by this authorPaul A Rundle
Search for more papers by this authorIan G Rennie
Search for more papers by this authorBook Editor(s):Richard Wormald,
Liam Smeeth,
Katherine Henshaw,
Anupa Shah,
Richard Wormald
Consultant Ophthalmologist, Moorfields Eye Hospital, Honorary Senior Lecturer, London School of Hygiene and Tropical Medicine and Coordinating Editor, Cochrane Eyes and Vision, Group, London, UK
Search for more papers by this authorLiam Smeeth
Senior Lecturer in Clinical Epidemiology, London School of Hygiene and Tropical Medicine, General Practitioner, London and Editor, Cochrane Eyes and Vision Group, London, UK
Search for more papers by this authorKatherine Henshaw
Review Group Coordinator, Cochrane Eyes and Vision Group, London, UK
Search for more papers by this authorAnupa Shah
Trial Search Coordinator, Cochrane Eyes and Vision Group, London, UK
Search for more papers by this authorFirst published: 01 January 2005
Summary
This chapter contains section titled:
-
Background
-
The Evidence
-
Implications for Practice
-
Implications for Research
-
References
References
-
Chang AE,
Karnell LH,
Menck HR.
The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society.
Cancer
1998;
83:
1664–78.
10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G CAS PubMed Web of Science® Google Scholar
- Dutton JJ, Anderson RL, Schelper RL, Purcell JJ, Tse DT. Orbital malignant melanoma and oculodermal melanocytosis: report of two cases and review of the literature. Ophthalmology 1984; 91: 497–507.
- Strickland D, Lee JA. Melanomas of eye: stability of rates. Am J Epidemiol 1981; 113: 700–2.
- Shields JA, Shields CL, Donoso LA. Management of posterior uveal melanoma. Surv Ophthalmol 1991; 36: 161–95.
- Anonymous. Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1. Arch Ophthalmol 1990; 108: 1268–73.
- Rigel D, Carucci JA. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin 2000b; : 215–36.
- Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmology 2003; 110: 956–61.
- Singh AD, Topham A. Survival rate with uveal melanoma in the United States: 1973–1997. Ophthalmology 2003; 110: 962–5.
- Donoso LA, Folberg R, Naids R. Metastatic uveal melanoma. Hepatic metastasis identified by hybridoma-secreted monoclonal antibody Mab 8–1H. Arch Ophthalmol 1985; 103: 799–801.
-
Eskelin S,
Pyrhonen S,
Summanen P et al.
Screening for metastatic malignant melanoma of the uvea revisited.
Cancer
1999;
85:
1151–9.
10.1002/(SICI)1097-0142(19990301)85:5<1151::AID-CNCR20>3.0.CO;2-G CAS PubMed Web of Science® Google Scholar
- Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS report no. 18. Arch Ophthalmol 2001; 119: 969–82.
- Straatsma BR, Fine SL, Earle JD et al. Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology 1988; 95: 1000–4.
- Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10. Am J Ophthalmol 1998; 125: 779–96.
- The Collaborative Ocular Melanoma Study Group. Mortality in patients with small choroidal melanoma. COMS report no. 4. Arch Ophthalmol 1997; 115: 886–93.
- Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells? Br J Ophthalmol 1978; 62: 420–5.
- Zimmerman LE, McLean IW. An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol 1979; 87: 741–60.
- Seigel D, Myers M, Ferris FR, Steinhorn S. Survival rates after enucleation of eyes with malignant melanoma. Am J Ophthalmol 1979; 87: 761–5.
- Augsburger JJ, Gamel JW, Lauritzen K, Brady LW. Cobalt-60 plaque radiotherapy v enucleation for posterior uveal melanoma. Am J Ophthalmol 1990; 109: 585–92.
- Augsburger JJ, Schneider S, Freire J, Brady LW. Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987. Graefe’s Arch Clin Exp Ophthalmol 1999; 237: 558–67.
- Seddon JM, Gragoudas ES, Egan KM et al. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 1990; 97: 769–77.
- Augsburger JJ, Lauritzen K, Gamel JW et al. Matched group study of surgical resection versus cobalt-60 plaque radiotherapy for primary choroidal or ciliary body melanoma. Ophthalmic Surg 1990; 21: 682–8.
- Kroll S, Char DH, Quivey J, Castro J. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma. Ophthalmology 1998; 105: 2035–45.
- Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma. Arch Ophthalmol 1992; 110: 245–50.
- Seregard S. Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients. Acta Ophthalmol Scand 1999; 77: 414–17.
